Evidence map›Paper›PMID 40661471›Full record

ArticlebioRxiv : the preprint server for biology2025

Depth-Resolved Macroscopic Fluorescence Lifetime Imaging via High-Spatial-Frequency Structured Illumination.

Nanxue Yuan, Saif Ragab, Navid Nizam, Vikas Pandey, Amit Verma, Tynan Young, John Williams, Margarida Barroso, Xavier Intes

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Nanxue YuanCenter for modeling, simulation and Imaging in Medicine, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Saif RagabCenter for modeling, simulation and Imaging in Medicine, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Navid NizamCenter for modeling, simulation and Imaging in Medicine, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Vikas PandeyCenter for modeling, simulation and Imaging in Medicine, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Amit VermaDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, New York 12208, USA.
Tynan YoungCity of Hope, Beck Research Institute, Department of Molecular Medicine, Duarte, CA 91016, USA.
John WilliamsCity of Hope, Beck Research Institute, Department of Molecular Medicine, Duarte, CA 91016, USA.
Margarida BarrosoDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, New York 12208, USA.ORCID 0000-0002-0407-3181
Xavier IntesCenter for modeling, simulation and Imaging in Medicine, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.

Funding

Role of tumor heterogeneity on receptor engagementR01CA207725 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, CORR, DAVID THOMAS · 2017 to 2021
$3.0M
In vivo Macroscopic Fluorescence Lifetime Molecular Optical ImagingR01CA250636 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, INTES, XAVIER · 2020 to 2023
$2.9M
Photon-counting X-ray and Optical Tomography for Preclinical Cancer ResearchR01CA237267 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, INTES, XAVIER · 2019 to 2023
$2.9M
AI enhanced lifetime-based mesoscopic in vivo imaging of tissue molecular heterogeneityR01CA271371 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI Margarida Barroso, Xavier Intes · 2023 to 2026
$2.7M
NCI NIH HHS R01 CA207725NCI NIH HHS R01 CA237267NCI NIH HHS R01 CA250636NCI NIH HHS R01 CA271371
6 · The paper itself

Abstract

Significance: Macroscopic Fluorescence Lifetime Imaging (MFLI) is a powerful, non-invasive imaging modality that offers robust, physiologically relevant contrast largely independent of fluorophore concentration, excitation intensity, and tissue signal attenuation. However, accurately determining the depth of signal origin remains challenging, potentially leading to ambiguity in biological interpretation. Here, we present a novel optical correction method that effectively eliminates surface signal bias, such as that from skin in preclinical imaging, without the need for chemical clearance. This advancement supports the robust applicability of MFLI in translational research. Aim: Establishment of a High Spatial Frequency-Fluorescence Lifetime Imaging (HSF-FLI) framework to selectively isolate subsurface fluorescence (deeper signals) from surface fluorescence, while preserving the accuracy of lifetime estimation. Approach: A modulation transfer function (MTF) that relates spatial frequency to penetration depth was derived using Monte Carlo eXtreme (MCX) simulations (for physics-based modeling) and validated with agar-based capillary phantoms on a time-gated ICCD-DMD system. Depth-independent fluorescence was decomposed into surface and subsurface components through structured three-phase sinusoidal illumination, and nonlinear least squares fitting was applied to recover lifetime or lifetime based parameters maps. HSF-FLI was demonstrated in vivo in mouse models bearing tumor xenogratfs and was cross validated with ex vivo measurements. Results: We extensively characterized the performance of High Spatial Frequency-Fluorescence Lifetime Imaging (HSF-FLI) through simulations and tissue-mimicking phantoms. The approach was further validated in vivo by assessing drug delivery in preclinical models using MFLI-FRET (Förster Resonance Energy Transfer). Conclusion: By coupling structured illumination with physics-based depth modeling, HSF-FLI delivers accurate, depth-selective lifetime readouts, setting the stage for robust and fast FLI implementation in translational studies.

Indexed as

FLIFRETHSFMCXMFLIStructured Light Illumination

Identifiers

PMID40661471
PMCPMC12259142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.